Sleep Duration, Quality, and Cardiovascular Risk

Sleep Duration, Quality, and Cardiovascular Risk

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.

These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.

In Brief: How much you sleep is the part of sleep most people track — and the crudest measure of whether sleep is protecting the heart. Across large studies the relationship between sleep duration and cardiovascular risk is U-shaped: both short sleep (under six hours) and long sleep (over eight to nine) are associated with more coronary disease and stroke. But the two are not the same kind of risk — short sleep appears to cause harm directly, while long sleep is usually a marker of underlying illness. Duration also misses what often matters more: whether sleep is uninterrupted and consistently timed, since two people with the same hours can have very different cardiovascular physiology. This article covers how much sleep the evidence supports, why quality determines whether those hours count, and how to tell whether your own sleep is doing its job.

Hours Are Only Part of the Story

Article 1 described what happens during healthy sleep: the progression through NREM and REM stages, the cardiovascular recovery concentrated in deep N3 sleep, and the autonomic shift that lowers blood pressure and heart rate for hours at a time when sleep is consolidated.

This article asks how much of that sleep you actually need, and how to tell whether you are getting it. Three questions organize it. First, how much is enough — complicated by a risk curve that turns upward at both short and long durations, and by the fact that most studies measure what people report rather than what they actually sleep. Second, what counts as quality — because duration is only one of three things that matter, alongside continuity and timing. Third, how to know whether your own sleep is adequate, given that feeling “fine” is one of the least reliable guides there is.

The throughline is the one from Article 1: sleep is a nightly cardiovascular exposure. When it is too short, broken up, or mistimed, the heart and blood vessels stay closer to daytime demand, and the cost shows up over years as higher rates of hypertension, coronary disease, stroke, and atherosclerosis. Article 3 then begins the specific sleep disorders with obstructive sleep apnea.

Sleep Duration and Cardiovascular Risk

The U-Shaped Curve

One of the most consistent findings in sleep epidemiology is that sleep duration and cardiovascular risk follow a U-shaped curve: risk is lowest in a middle range and rises at both short and long durations.(1)

The largest synthesis is the Cappuccio meta-analysis, which pooled over 470,000 participants across 15 prospective studies followed for 7 to 25 years. Short sleep — generally under six hours — was associated with a 48% higher risk of developing or dying from coronary heart disease and a 15% higher risk of stroke. Long sleep — generally more than eight to nine hours — was associated with a 38% higher risk of coronary heart disease and a 65% higher risk of stroke.(1) These are relative risks; turning them into absolute numbers depends on a person’s age, sex, and baseline risk and cannot be read directly off the meta-analysis.

Other large cohorts point the same way. The MORGEN study followed about 20,000 Dutch adults for 10 to 15 years and found each hour of sleep below seven associated with a 6% increase in cardiovascular disease incidence.(2) The Nurses’ Health Study, following 71,000 women, found the highest coronary heart disease incidence in those sleeping five hours or less.(3)

These are observational associations, not randomized trials, and people who sleep poorly differ in other ways that affect risk. But the consistency across very different populations, the dose-response pattern, and the alignment with mechanisms shown in experimental studies make the association a meaningful one.(1, 2, 3, 4, 5)

Plotted, the relationship forms a shallow U: cardiovascular risk is lowest at roughly seven to eight hours and rises at both ends. The two arms are not equivalent, though — the short-sleep (left) arm reflects direct, demonstrated harm, while the long-sleep (right) arm largely reflects association, often a marker of underlying illness rather than a cause.

What the Duration Numbers Actually Measure

Most of this evidence rests on self-reported sleep — what people say when asked how long they sleep. That number is softer than it looks. It blends real sleep with time spent in bed trying to fall asleep or lying awake, so many people overestimate. “Short sleep” can mean too little time in bed or enough time in bed used inefficiently; “long sleep” can mean genuinely sleeping more or simply spending more hours in bed because sleep is poor or health is failing. The associations are real, but reported hours are an imperfect stand-in for the physiological exposure — which is part of why duration alone never tells the whole story.

The Reference Range

Guidelines from the American Academy of Sleep Medicine and the Sleep Research Society recommend 7 to 9 hours for adults, and in cohort studies the lowest cardiovascular risk tends to cluster around 7 to 8 reported hours.(6) That range is best treated as a reference point, not a target to hit precisely. It reflects population averages — individual need varies and is partly genetic — and it measures duration only. Someone who sleeps seven consolidated hours may do better, cardiovascularly, than someone who spends eight broken hours in bed.

Short Sleep: Direct Cardiovascular Harm

Consistently sleeping under six hours is associated with direct, measurable cardiovascular harm, and here the mechanism is not in doubt.(1, 4, 5) When healthy volunteers are restricted to four to six hours for days to weeks, the same changes appear repeatedly: blood pressure rises (during sleep and the next day), sympathetic activity increases, heart rate variability falls, and the endothelium becomes less able to dilate.(4, 5, 7, 8) Other changes show up less consistently, varying by protocol — rising inflammatory markers (CRP, IL-6), insulin resistance, and shifted cortisol patterns.(4, 5, 8) These effects emerge within days and largely reverse with recovery sleep, which makes them functional dysregulation rather than immediate structural damage.(9) But chronic short sleep means the exposure is chronic.

The risk also tracks with degree: across cohorts, shorter sleep generally means higher cardiovascular risk, though the exact cutpoints differ between studies.(10) And short sleep is not a fringe problem — about 35% of U.S. adults report under seven hours a night, driven by work, caregiving, commuting, and screens.(11) Many of them do not feel sleep-deprived, because people adapt to chronic short sleep: after weeks of it, performance is impaired but the sense of impairment fades, and the memory of being fully rested fades with it.(12) The cardiovascular system does not adapt the same way — it keeps accumulating the exposure.

Long Sleep: A Marker More Than a Cause

Sleeping more than eight to nine hours also tracks with higher cardiovascular risk in epidemiological studies, but it should be read very differently.(1) Short sleep has experimental proof of harm; long sleep has almost none — no controlled study has shown that sleeping nine-plus hours injures blood vessels. The association is better explained by reverse causation and confounding.(13) Chronic illness such as heart failure, COPD, or cancer causes fatigue and more time in bed; depression — itself a cardiovascular risk factor — is associated with sleeping long; fragmenting sleep disorders push people to spend longer in bed to compensate; systemic inflammation raises sleep drive; and sedating medications lengthen sleep.

The clinical difference is practical. For someone sleeping five hours, extending toward seven or eight addresses the exposure directly. For someone sleeping ten, setting an alarm for seven will not help and may feel worse — the useful question is why they need ten, because the answer usually points to something else that needs attention.(13) The distinction matters: long sleep is probably not injuring your arteries the way short sleep does, but a persistent need for unusually long sleep is still worth investigating for what it reveals. Long sleep is a signal, not the problem.

A Note on Temporary Increases in Sleep Need

None of this means a sudden need for more sleep is a warning sign. During an infection, after surgery, through a stretch of intense physical training, or under major stress, the body’s sleep need genuinely rises, and extra sleep and daytime naps are part of how it recovers and supports the immune response. That kind of increase is normal and self-limited; it eases as recovery does. What deserves attention is the persistent, unexplained version — needing ten hours month after month with no acute reason — not the temporary rise that comes with being unwell, healing, or worn down.

The Other Direction: Extending Short Sleep

Most of this evidence is about taking sleep away. The reverse question — what happens when chronically short sleepers get more — has less direct data, but the restriction studies point the way: because the changes they cause reverse with recovery sleep, lengthening genuinely insufficient sleep should move the same markers in the right direction.(4, 5, 9, 22) Daytime alertness and function reliably improve.(9, 22) What is missing is the long-term outcome evidence — no large trial has shown that sleep extension lowers hard cardiovascular events. So the honest read is narrow but useful: extending short sleep clearly helps how you feel and the short-term markers, and is very likely protective over time, with the definitive proof still outstanding.

From Reported Hours to Measured Plaque: The PESA Study

Most of the evidence above rests on what people say they sleep. The PESA study measured what they actually did, and what it did to their arteries.(14) Nearly 4,000 middle-aged adults in Spain with no known cardiovascular disease wore actigraphy devices to track sleep objectively and underwent vascular imaging — carotid and femoral ultrasound and coronary CT for calcium scoring. Short sleep (under six hours) was associated with more atherosclerosis across several vascular beds, consistent with the cohort data. But fragmented sleep was also associated with more atherosclerosis independent of how long people slept, and the two together were worse than either alone.

What makes PESA stand out is that it paired objective sleep measurement with objective vascular imaging, rather than relying on self-reported sleep and waiting for future events — both the exposure and the damage were measured directly. It is still observational and captured sleep over a limited window, so it cannot prove cause. What it shows is that two people with the same hours can carry different amounts of plaque depending on whether those hours were continuous — which is where duration stops being enough.

Why Quality Matters as Much as Hours

The Three Components of Quality

In ordinary use “quality” is vague. In sleep medicine it has three measurable parts: duration (enough total sleep), continuity (uninterrupted sleep that allows sustained NREM recovery), and timing (a consistent schedule aligned with the body clock). All three affect cardiovascular outcomes. Duration is the one most people track, and the crudest of the three.

The Problem with Counting Hours

Take two people who both report seven hours. The first falls asleep in fifteen minutes, sleeps through with only brief awakenings, and wakes after about six and a half consolidated hours — most of it spent in sustained NREM recovery, blood pressure down and sympathetic tone low. The second lies awake for an hour, wakes four times, and rarely holds deep sleep before being pulled back to lighter stages, ending up with maybe five fragmented hours inside eight in bed. Same reported number. Different cardiovascular night.

Sleep Efficiency

Sleep efficiency is the share of time in bed actually spent asleep — total sleep time divided by time in bed, times 100.(15) Someone in bed eight hours who sleeps about seven and a half is running roughly 94%; someone in bed nine hours who actually sleeps about six is at about 67% — and looks like a long sleeper while really getting short sleep. Above about 85% is the usual benchmark.(15) Low efficiency means fragmented or prolonged wakefulness, and that is where the cardiovascular cost sits. Each awakening pulls the system out of the parasympathetic state that should dominate sleep, so the sustained nocturnal blood-pressure dip never fully takes hold.(16) Over months and years, that raises the nighttime blood-pressure load and shrinks the cumulative time the heart spends recovering.(13, 15)

Why Interruptions Matter: Sleep Fragmentation

Fragmentation is not the same as short sleep, and it does its own damage.(16, 17) Each arousal — even a three-to-fifteen-second one the person never remembers — triggers a brief surge of sympathetic activity and a spike in blood pressure and heart rate. It also pulls the system out of the NREM pattern.(16) Strung together, those surges keep blood pressure from settling and keep the night from reaching and holding deep N3.(17) In obstructive sleep apnea the arousals can come dozens of times an hour, so a person can spend eight hours in bed and get almost no real recovery.(18) This is the mechanism behind the PESA finding: fragmented sleep was tied to more atherosclerosis even when duration looked adequate.(14)

Sleep Opportunity vs. Sleep Ability

A useful way to sort these problems is to separate two different things sleep requires. Sleep opportunity is having enough time set aside for sleep. Sleep ability is the capacity to actually generate sleep during that time. They fail in opposite directions and call for opposite fixes. An opportunity problem — too little time in bed because of work, caregiving, or a long commute — needs more time, not a supplement. An ability problem — insomnia, or sleep apnea breaking up the night — has the time but cannot convert it into restorative sleep, and piling on more time in bed often makes insomnia worse rather than better. A great deal of wasted effort comes from confusing the two. People pour money into melatonin and sleep hacks when the real issue is opportunity, or stretch time in bed for years to fix an ability problem that needs treatment.

The same “seven to eight hours in bed” can therefore hide very different problems. The table is a rough guide to which one a given pattern usually reflects, and what it points toward.

If sleep feels unrefreshing despite adequate time in bed, the problem is more often ability than opportunity — quality, not quantity.

The “Short Sleeper” Question

True short sleepers exist — people who do well on under six hours with no daytime impairment or health cost. The trait is genetic, tied to specific variants such as those in DEC2/BHLHE41, and it is rare.(20) Most people who consider themselves short sleepers are chronically sleep-deprived and have adapted to it.

The adaptation is the trap. After enough weeks of short sleep, the acute exhaustion dulls, the impaired state starts to feel normal, and “I’m fine on six hours” becomes an unreliable report — because the organ doing the assessing is the one that is impaired.(12) Baseline sleep need appears biologically set; people habituate to feeling less impaired, but the objective deficits, and the cardiovascular exposure, continue.(12, 21)

The simplest way clinicians separate the two patterns is shown below.

In practice the most telling item is the last one: on a free morning with no alarm and no obligations, a true short sleeper still wakes on their own after five or six hours, while most self-described short sleepers sleep well past that.(12, 20) If you reliably sleep longer when given the chance, you are carrying debt, not running on a smaller tank.

Sleep Debt: Can You Catch Up?

When sleep falls short, a debt accumulates — the gap between what you needed and what you got.(9) Whether it can be repaid depends on the timescale.

Acute debt largely recovers. A few short nights can be substantially made up over the following nights: blood pressure normalizes, endothelial function improves, inflammatory markers come down, and the measurable deficits mostly resolve within a night or two of unrestricted sleep.(4, 5, 22)

Chronic debt is the open question. After months or years of five-to-six-hour nights, whether the cardiovascular effects fully reverse with later adequate sleep is unknown.(9) The weekday-short, weekend-long pattern has been studied with mixed results — some signs of partial benefit, some persistent association with risk.(23)

The catch is a mismatch in timescales. The things that recover fast — blood pressure, endothelial function, inflammation — are not the things that matter most over a lifetime.(4, 5) Atherosclerosis builds over years to decades, and whether it unwinds when sleep improves is not known.(14) That is why “I’ll catch up later” is a biological gamble: how you feel recovers quickly, but the structural risk may not. The safer assumption is that chronic debt compounds, and that preventing it matters more than trying to repay it.

Timing and Regularity

Duration is how much, continuity is how consolidated, and timing is when — and whether the when is consistent.

Blood pressure, heart rate, cortisol, and much of metabolism run on circadian rhythms, and part of sleep’s cardiovascular benefit depends on sleep lining up with them. Sleep taken at the wrong circadian time — shift work, severe jet lag — is lighter and more broken even when it is long enough. Deep sleep is harder to reach against the clock’s drive for wakefulness, and the nocturnal blood-pressure dip may not fully happen.(24)

The everyday version is social jet lag: short, alarm-cut nights on weekdays (say, midnight to 5:30 AM) and long, late ones on weekends (1 AM to 10 AM). The weekly average can look acceptable — around six and a half hours. But it stacks three problems: chronic restriction Monday to Friday, recovery attempts that may be incomplete, and a body clock shoved back and forth by two to three hours twice a week. Social jet lag has been associated with more obesity and adverse metabolic markers in observational studies, though cause is not established.(24, 25) Circadian disruption and shift work get their own treatment in Article 6; the point here is that seven hours taken at ragged, shifting times is not the same cardiovascular exposure as seven hours taken consistently.

How Sleep Feeds the Cardiometabolic System

The threads in this article — higher blood pressure, sympathetic activation, inflammation, insulin resistance — do not run in parallel. They converge. Short and fragmented sleep raise sympathetic tone, shift cortisol, and promote insulin resistance,(4, 5, 8) and circadian misalignment adds its own metabolic cost.(24) Insulin resistance is the hub of the cluster known as metabolic syndrome — visceral fat, higher blood pressure, an adverse lipid profile, and rising blood glucose — which in turn drives hypertension, type 2 diabetes, and atherosclerosis. That is why HeartBuddi treats sleep not as a standalone habit but as an upstream input to the whole cardiometabolic system, where a change in one domain propagates through the rest. The metabolic side of that system is the subject of Article 8.

Assessing Your Own Sleep

Because the feeling of sleeping well is unreliable, it helps to look at sleep more concretely. None of this replaces medical evaluation, but it sharpens what you bring to it.

Estimating real sleep. Time in bed is not sleep time, and the gap between them is what sleep efficiency captures. Tracking for one to two weeks — when you got into bed, roughly when you fell asleep, awakenings and their length, when you woke, and when you got up — lets you estimate actual sleep and efficiency rather than guessing. In practice, a short sleep log often shows what a single clinic question cannot: that the “eight hours” someone reports is really six and a half spent asleep inside eight in bed.

Checking continuity. A few questions characterize whether sleep is consolidated. How long does it take to fall asleep (fifteen to thirty minutes is typical; much longer suggests trouble initiating, much shorter can signal heavy sleep debt)? How often, and how long, do you wake? Do you wake rested or still tired? Do you doze off unintentionally during the day — watching television, as a passenger, in a meeting — despite enough time in bed? And does a bed partner notice snoring, gasping, or pauses in breathing? Unintentional daytime sleepiness despite adequate time is a particularly useful flag, because it often points to fragmentation the person cannot feel.

The free-morning test. What happens on a day with no alarm and no obligations is informative. Sleeping about the same length suggests weekday sleep is adequate; sleeping two or more hours longer suggests accumulated debt; sleeping much longer and still feeling tired points toward a quality problem — fragmentation, a disorder, or underlying illness.

Trackers, and their limits. Wearables and apps estimate sleep with variable accuracy.(26) They can approximate timing and total duration, flag major awakenings, and show trends over weeks. They are far less reliable at distinguishing sleep stages (especially light versus deep NREM), catching the brief arousals that fragment sleep, or identifying a disorder.(26) They are useful for spotting patterns, not for diagnosis: if a tracker suggests a problem, the right response is clinical evaluation, not redesigning your life around the device’s score. There is even a recognized downside — orthosomnia, where fixation on sleep numbers breeds anxiety that itself worsens sleep.(27) The goal is restorative sleep, not a perfect score.

When to Consider a Sleep Evaluation

Clinicians tend to consider a formal sleep evaluation when time in bed is clearly not translating into restorative sleep, or when the cardiovascular picture raises concern for sleep-disordered breathing. On the duration side, that includes persistent short sleep despite the opportunity for more, or persistent long time in bed that still leaves a person unrefreshed. On the quality side: loud snoring, witnessed pauses or gasping, daytime sleepiness out of proportion to reported hours, trouble falling or staying asleep despite adequate opportunity, or waking unrefreshed despite enough time. The cardiovascular context lowers the threshold considerably — hypertension that resists multiple medications, non-dipping blood pressure on ambulatory monitoring, atrial fibrillation (especially nocturnal), and heart failure with nighttime symptoms all warrant a closer look.

One caution matters here: the cardiovascular risk from sleep-disordered breathing can be present even in people who do not feel especially sleepy, so the absence of sleepiness does not rule out clinically significant apnea. The threshold for evaluation is lower still in anyone with established cardiovascular disease, where sleep disorders are common and frequently untreated. A sleep study — in-lab polysomnography or home testing — is the way to identify conditions like obstructive sleep apnea that duration tracking alone will miss; Article 3 covers that disorder in detail.

What This Means for Your Cardiovascular Health

If you have no known cardiovascular disease, treat sleep as a modifiable risk factor alongside blood pressure, cholesterol, and exercise. Population data put the lowest risk around seven to eight hours, useful as a reference rather than a precise target; continuity may matter as much as duration; consistent timing avoids the restriction-plus-misalignment of social jet lag; and when enough hours still don’t feel restorative, the issue is usually quality, not quantity.

If you have hypertension, sleep affects blood pressure regulation directly.(4, 7) Short sleep raises it, fragmentation blocks the nocturnal dip, and sleep apnea is both common in hypertension and a frequent reason pressure resists treatment. When blood pressure won’t come down despite multiple drugs, a sleep evaluation may find a contributing cause — developed in Article 3.

If you have coronary artery disease, the mechanisms of poor sleep — sympathetic activation, inflammation, endothelial dysfunction — are the same ones that destabilize coronary disease.(4, 5, 8) Adequate, consolidated sleep means hours of lower cardiac demand each night; poor sleep means the opposite.

If you have heart failure, sleep-disordered breathing — obstructive, central, or both — is present in most patients, and the relationship runs both ways: heart failure disrupts sleep, and disordered breathing worsens heart failure. Excess fatigue and a need for long sleep may reflect the disease, its medications, or unrecognized apnea, and telling them apart matters for management. Articles 3 and 4 address this directly.

If you have atrial fibrillation, sleep apnea is common and is associated with recurrence after rhythm treatment in observational studies, though outcomes depend on phenotype and adherence. If AF is hard to control or returns after cardioversion or ablation, a sleep evaluation may be relevant — covered in Article 3, and in Article 8 for the broader cardiometabolic links.

Common Assumptions Measured Against the Physiology

The Bottom Line

Duration is the part of sleep easiest to measure and easiest to misread. In the largest meta-analysis, under six reported hours carried about 48% higher coronary risk, with the lowest risk around seven to eight hours; long sleep raises risk too, but mostly as a marker of underlying illness rather than a cause.(1, 13) Hours alone miss what often matters more. The PESA study tied fragmented sleep to more atherosclerosis even when duration looked adequate — two people reporting the same hours can carry different plaque depending on whether those hours were continuous.(14) The cardiovascular system does not count time in bed; it responds to whether sustained NREM recovery actually happened, which takes enough sleep, uninterrupted sleep, and consistently timed sleep. The useful shift is from one question — how many hours? — to those three, because chasing a single number, increasingly the figure on a wrist device, can backfire into the very sleep anxiety it was meant to solve. And sleep is an exposure met every night, roughly 365 times a year for a lifetime: few cardiovascular risk factors recur so predictably, which means poor sleep compounds night after night — but so does the benefit of getting it right.

What Comes Next

Article 3 turns to obstructive sleep apnea — the most common sleep disorder and one of the most underdiagnosed cardiovascular risk factors. It is present in a large share of patients with hypertension, atrial fibrillation, and heart failure who were never evaluated for it.

Key Terms

Sleep efficiency: The percentage of time in bed actually spent asleep, calculated as (total sleep time ÷ time in bed) × 100. Values below about 85% indicate significant time awake from prolonged sleep onset, awakenings, or both.

Sleep fragmentation: Interruption of sleep by brief arousals or awakenings. Causes sympathetic activation and prevents sustained cardiovascular recovery, even when total sleep time looks adequate.

U-shaped curve: The relationship between sleep duration and cardiovascular risk in which both short sleep (under six hours) and long sleep (over eight to nine hours) carry higher risk than the middle range.

Social jet lag: The discrepancy between sleep timing on workdays and free days. Large differences indicate chronic circadian misalignment, sleep restriction during the workweek, or both.

Sleep debt: The cumulative gap between sleep needed and sleep obtained. Acute debt can largely be recovered with extended sleep; whether chronic debt can be fully repaid is uncertain.

Actigraphy: Estimation of sleep-wake patterns from a wrist-worn movement sensor, used to track sleep over extended periods outside a sleep laboratory.

Polysomnography: Comprehensive in-laboratory sleep study measuring brain waves, eye movements, muscle activity, heart rhythm, and breathing. The reference standard for diagnosing sleep disorders.

Nocturnal dipping: The normal fall in blood pressure during sleep relative to daytime. Fragmented sleep and sleep-disordered breathing can blunt or abolish it.

Orthosomnia: Anxiety about achieving “perfect” sleep, often driven by sleep-tracker data, that can itself worsen sleep.

References

1. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484-1492. doi:10.1093/eurheartj/ehr007.
2. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep. 2011;34(11):1487-1492. doi:10.5665/sleep.1382. PMID: 22043119.
3. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205-209. doi:10.1001/archinte.163.2.205. PMID: 12546611.
4. Tobaldini E, Costantino G, Solbiati M, et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. 2017;74(Pt B):321-329. doi:10.1016/j.neubiorev.2016.07.004. PMID: 27397854.
5. Sauvet F, Leftheriotis G, Gomez-Merino D, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol. 2010;108(1):68-75. doi:10.1152/japplphysiol.00851.2009. PMID: 19910332.
6. Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38(6):843-844. doi:10.5665/sleep.4716.
7. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens. 1999;12(1 Pt 1):63-68. doi:10.1016/S0895-7061(98)00200-3. PMID: 10075386.
8. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40-52. doi:10.1016/j.biopsych.2015.05.014. PMID: 26140821.
9. Banks S, Van Dongen HP, Maislin G, Dinges DF. Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery. Sleep. 2010;33(8):1013-1026. doi:10.1093/sleep/33.8.1013. PMID: 20815182.
10. Yin J, Jin X, Shan Z, et al. Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc. 2017;6(9):e005947. doi:10.1161/JAHA.117.005947. PMID: 28889101.
11. Liu Y, Wheaton AG, Chapman DP, Cunningham TJ, Lu H, Croft JB. Prevalence of healthy sleep duration among adults—United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(6):137-141. doi:10.15585/mmwr.mm6506a1. PMID: 26890214.
12. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26(2):117-126. doi:10.1093/sleep/26.2.117. PMID: 12683469.
13. Grandner MA, Drummond SP. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev. 2007;11(5):341-360. doi:10.1016/j.smrv.2007.03.010. PMID: 17625932.
14. Domínguez F, Fuster V, Fernández-Alvira JM, et al. Association of sleep duration and quality with subclinical atherosclerosis. J Am Coll Cardiol. 2019;73(2):134-144. doi:10.1016/j.jacc.2018.10.060.
15. Reed DL, Sacco WP. Measuring sleep efficiency: what should the denominator be? J Clin Sleep Med. 2016;12(2):263-266. doi:10.5664/jcsm.5498. PMID: 26194727.
16. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest. 2010;137(1):95-101. doi:10.1378/chest.09-0791. PMID: 19542260.
17. Ekstedt M, Åkerstedt T, Söderström M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med. 2004;66(6):925-931. doi:10.1097/01.psy.0000145821.25453.f7. PMID: 15564359.
18. Wolf J, Hering D, Narkiewicz K. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res. 2010;33(9):867-871. doi:10.1038/hr.2010.153. PMID: 20818398.
19. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.
20. Pellegrino R, Kavakli IH, Goel N, et al. A novel BHLHE41 variant is associated with short sleep and resistance to sleep deprivation in humans. Sleep. 2014;37(8):1327-1336. doi:10.5665/sleep.3924.
21. Cirelli C, Tononi G. Is sleep essential? PLoS Biol. 2008;6(8):e216. doi:10.1371/journal.pbio.0060216. PMID: 18752355.
22. Belenky G, Wesensten NJ, Thorne DR, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res. 2003;12(1):1-12. doi:10.1046/j.1365-2869.2003.00337.x.
23. Hwangbo Y, Kim WJ, Chu MK, Yun CH, Yang KI. Association between weekend catch-up sleep duration and hypertension in Korean adults. Sleep Med. 2013;14(6):549-554. doi:10.1016/j.sleep.2013.02.009. PMID: 23643647.
24. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106(11):4453-4458. doi:10.1073/pnas.0808180106.
25. Roenneberg T, Allebrandt KV, Merrow M, Vetter C. Social jetlag and obesity. Curr Biol. 2012;22(10):939-943. doi:10.1016/j.cub.2012.03.038. PMID: 22578422.
26. de Zambotti M, Goldstone A, Claudatos S, Colrain IM, Baker FC. A validation study of Fitbit Charge 2™ compared with polysomnography in adults. Chronobiol Int. 2018;35(4):465-476. doi:10.1080/07420528.2017.1413578. PMID: 29235907.
27. Baron KG, Abbott S, Jao N, Manber N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? J Clin Sleep Med. 2017;13(2):351-354. doi:10.5664/jcsm.6472. PMID: 27855740.

HeartBuddi • Your heart. Own it.